Medlab Clinical (AU:MDC) has released an update. Medlab Clinical Limited reported a significant 98.7% drop in revenue, amounting to just $11,894, and a reduced net loss of $2.13 million for the year ...
Medlab is an Australian ASX-listed biotechnology company finding new ways to address some of the biggest health challenges of our time – including managing depression and opioid-alternatives to pain ...
PERTH, Australia – After meeting with the FDA, Medlab Clinical Ltd. is reformulating its cannabinoid pain product into a synthetic formulation because the agency indicated it was more likely to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results